Gene expression changes are age-dependent and lobe-specificin the Brown Norway rat model of prostatic hyperplasia

Prostate

Volumn 69, Issue 8, 2009, Pages 838-850

  Bethel, Carlise R ^a   Chaudhary, Jaideep ^b   Anway, Matthew D ^c   Brown, Terry R ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

^c UNIVERSITY OF IDAHO   (United States)

Author keywords

Age; Gene expression; Hyperplasia; Microarray; Prostate

Indexed keywords

AURORA B KINASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE P1; STATHMIN; STATHMIN 1; TOPOISOMERASE 2 ALPHA; UNCLASSIFIED DRUG; PRIMER DNA; PROTEIN; RNA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; ANIMAL; CLUSTER ANALYSIS; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; NUCLEIC ACID HYBRIDIZATION; ORCHIECTOMY; PHYSIOLOGY;

AGING; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORCHIECTOMY; PROSTATIC HYPERPLASIA; PROTEINS; RATS; RATS, INBRED BN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 65549142546     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20935     Document Type: Article

References (58)

1. Roehrborn CG, McConnell JD. Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell Walsh Urology, 9th edition. Chapter 86. Philadelphia: Saunders; 2007. pp 2727-2765.
2. Oesterling JE. Benign prostatic hyperplasia: A review of its histogenesis and natural history. Prostate Suppl 1996;6:67-73.
3. Banerjee PP, Banerjee S, Dorsey R, Zirkin BR, Brown TR. Age- and lobe-specific responses of the brown Norway rat prostate to androgen. Biol Reprod 1994;51:675-684. (Pubitemid 24284400)
4. Banerjee PP, Banerjee S, Lai JM, Strandberg JD, Zirkin BR, Brown TR. Age-dependent and lobe-specific spontaneous hyperplasia in the Brown Norway rat prostate. Biol Reprod 1998;59:1163-1170. (Pubitemid 28498928)
5. Zirkin BR, Chen H. Regulation of Leydig cell steroidogenic function during aging. Biol Reprod 2000;63:977-981.
6. Banerjee S, Banerjee PP, Brown TR. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age. Endocrinology 2000;141:821-832. (Pubitemid 32250508)
7. Banerjee PP, Banerjee S, Brown TR. Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the Brown Norway rat prostate. Endocrinology 2001;142:4066-4075. (Pubitemid 32802680)
8. Banerjee PP, Banerjee S, Brown TR. Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology 2002;143:825-832. (Pubitemid 34415898)
9. Yan J, Brown TR. Cell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasia. Endocrinology 2008;149:193-207.
10. Zhao H, Patra A, Yeh CC, Tanaka Y, Oh BR, Dahiya R. Effects of aging on growth factor gene and protein expression in the dorsal and ventral lobes of rat prostate. Biochem Biophys Res Commun 2002;292:482-491. (Pubitemid 34694290)
11. Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK, Ho SM. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Lab Invest 2003;83:743-757. (Pubitemid 36618052)
12. Isaacs JT. The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res 1984;44:5785-5796. (Pubitemid 15183594)
13. Reyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J. Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. Prostate 2005;63:169-186.
14. van der Heul-Nieuwenhuijsen L, Hendriksen PJ, van der Kwast TH, Jenster G. Gene expression profiling of the human prostate zones. BJU Int 2006;98:886-897. (Pubitemid 44368045)
15. Pollard M. Spontaneous prostate adenocarcinomas in aged germ-free Wistar rats. J Natl Cancer Inst 1973;51:1235-1241.
16. Leav I, McNeal JE, Ziar J, Alroy J. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Hum Pathol 1998;29:668-675. (Pubitemid 28322050)
17. Hoover DM, Bendele AM, Hoffman WP, Foxworthy PS, Eacho PI. Effects of chronic treatment with the leukotriene D4 antagonist compound LY171883 on Fischer 344 rats and rhesus monkeys. Fund Appl Toxicol 1990;14:123-130. (Pubitemid 20097362)
18. Noble RL. Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 1982;23:113-159.
19. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 1994;54:3413-3421. (Pubitemid 24225960)
20. Asirvatham AJ, Schmidt M, Gao B, Chaudhary J. Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 2006;147:257-271. (Pubitemid 43004280)
21. Morrison C, Henzing AJ, Jensen ON, Osheroff N, Dodson H, Kandels-Lewis SE, Adams RR, Earnshaw WC. Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate. Nucl Acids Res 2002;30:5318-5327. (Pubitemid 36033051)
22. Gadea BB, Ruderman JV. Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin. Proc Natl Acad Sci USA 2006;103:4493-4498.
23. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V, Siavoshian S, Maucuer A, Sobel A. Stathmin and its phosphoprotein family: General properties, biochemical and functional interaction with tubulin. Cell Struct Funct 1999;24:345-357.
24. Bakshi RP, Galande S, Bali P, Dighe R, Muniyappa K. Developmental and hormonal regulation of type IIDNA topoisomerase in rat testis. J Mol Endocrinol 2001;26:193-206. (Pubitemid 32514610)
25. Metafora S, Peluso G, Persico P, Ravagnan G, Esposito C, Porta R. Immunosuppressive and anti-inflammatory properties of a major protein secreted from the epithelium of the rat seminal vesicles. Biochem Pharmacol 1989;38:121-131. (Pubitemid 19029163)
26. Vercaeren I, Vanaken H, Van Dorpe J, Verhoeven G, Heyns W. Expression of cystatin-related protein and of the C3-component of prostatic-binding protein during postnatal development in the rat ventral prostate and lacrimal gland. Cell Tissue Res 1998;292:115-128. (Pubitemid 28143883)
27. Winderickx J, Hemschoote K, De Clercq N, Van Dijck P, Peeters B, Rombauts W, Verhoeven G, Heyns W. Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Mol Endocrinol 1990;4:657-667. (Pubitemid 20156998)
28. Suzuki T, Fujimoto N, Kitamura S, Ohta S. Quantitative determination of lobe specificity of mRNA expression of androgen-dependent genes in the rat prostate gland. Endocr J 2007;54:123-132. (Pubitemid 46481680)
29. Cookson MS, Reuter VE, Linkov I, Fair WR. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 1997;157:673-676.
30. Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, FlickMB,KacinskiBM,Palotie A,WitteON.Expression of colonystimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci USA 2002;99:14404-14409. (Pubitemid 35257684)
31. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R. Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 1994;10:151-159.
32. Dhanasekaran SM, Dash A, Yu J, Maine IP, Laxman B, Tomlins SA, Creighton CJ, Menon A, Rubin MA, Chinnaiyan AM. Molecular profiling of human prostate tissues: Insights into gene expression patterns of prostate development during puberty. FASEB J 2005;19:243-245.
33. Cobb J, Reddy RK, Park C, Handel MA. Analysis of expression and function of topoisomerase I and II during meiosis in male mice. Mol Reprod Dev 1997;46:489-498. (Pubitemid 27149084)
34. Willman JH, Holden JA. Immunohistochemical staining forDNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate. Prostate 2000;42:280-286. (Pubitemid 30104571)
35. Hughes C, Murphy A, Martin C, Fox E, Ring M, Sheils O, Loftus B, O'Leary J. Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma. J Clin Pathol 2006;59:721-724. (Pubitemid 44048781)
36. Katayama H, Brinkley WR, Sen S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003;22:451-464.
37. Honda R, Korner R, Nigg EA. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol Biol Cell 2003;14:3325-3341. (Pubitemid 37013130)
38. Delacour-Larose M, Thi MN, Dimitrov S, Molla A. Role of survivin phosphorylation by aurora B in mitosis. Cell Cycle 2007;6:1878-1885. (Pubitemid 47327906)
39. Tanaka TU, Rachidi N, Janke C, Pereira G, Galova M, Schiebel E, Stark MJ, NasmythK. Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections. Cell 2002;108:317-329.
40. Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, Peters JM. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003;161:281-294. (Pubitemid 36529847)
41. Chieffi P, Cozzolino L, Kisslinger A, Libertini S, Staibano S, Mansueto G, De Rosa G, Villacci A, Vitale M, Linardopoulos S, Portella G, TramontanoD. Aurora Bexpression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 2006;66:326-333.
42. Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res 2002;62:5168-5177.
43. Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F, Terada Y. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 1998;58:4811-4816. (Pubitemid 28503674)
44. Ghosh R, Gu G, Tillman E, Yuan J, Wang Y, Fazli L, Rennie PS, Kasper S. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. Prostate 2007;67:1038-1052. (Pubitemid 46983334)
45. Guillaume E, Evrard B, Com E, Moertz E, Jegou B, Pineau C. Proteome analysis of rat spermatogonia: Reinvestigation of stathmin spatio-temporal expression within the testis. Mol Reprod Dev 2001;60:439-445.
46. Bettuzzi S, Strocchi P, Marinelli M, Astancolle S, Davalli P, Corti A. Gene relaxation and aging: Changes in the abundance of rat ventral prostate SGP-2 (clusterin) and ornithine decarboxylase mRNAs. FEBS Lett 1994;348:255-258.
47. Marinelli M, Quaglino D, Bettuzzi S, Strocchi P, Davalli P, Corti A. Increased levels of clusterin mRNA in the ventral prostate of the aging rat are associated to increases in cuboidal (atrophic) cell population and not to changes in apoptotic activity. Biochem Cell Biol 1994;72:515-521.
48. Rosenberg ME, Silkensen J. Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-645.
49. Sensibar JA, Griswold MD, Sylvester SR, Buttyan R, Bardin CW, Cheng CY, Dudek S, Lee C. Prostatic ductal system in rats: Regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology 1991;128:2091-2102.
50. Omwancha J, Anway MD, Brown TR. Differential age-associated regulation of clusterin expression in prostate lobes of Brown Norway rats. Prostate 2009;69:115-125.
51. Sano K, Maeda K, Oda T, Maeda Y. The effect of single residue substitutions of serine-283 on the strength of head-to-tail interaction and actin binding properties of rabbit skeletal muscle alphatropomyosin. J Biochem 2000;127:1095-1102. (Pubitemid 30430166)
52. Houle F, Rousseau S, Morrice N, Luc M, Mongrain S, Turner CE, Tanaka S, Moreau P, Huot J. Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: Impact on membrane blebbing. Mol Biol Cell 2003;14:1418-1432.
53. Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S, Hellstrom M, Linder S, Bergman T, Jornvall H, Auer G. Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 2001;58:307-311. (Pubitemid 32217362)
54. Hassan R, Bera T, Pastan I. Mesothelin: A new target for immunotherapy. Clin Cancer Res 2004;10:3937-3942.
55. Frierson HF Jr, , Moskaluk CA, Powell SM, Zhang H, Cerilli LA, Stoler MH, Cathro H, Hampton GM. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum Pathol 2003;34:605-609. (Pubitemid 36750373)
56. Rao AV, Shaha C. Multiple glutathione S-transferase isoforms are present on male germ cell plasma membrane. FEBS Lett 2001;507:174-180. (Pubitemid 33001537)
57. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer riskinmiddle-agedmen.Prostate 2006;66:146-156.
58. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, Morais A, Oliveira J, Lopes C. Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004;58:414-420.